Khosrow Mahdavi

Interferon-α2a and 13-cis-retinoic acid with radiationtreatment for high-grade glioma

Robert O. Dillman, William M. Shea, D. F. Tai et al. · Neuro-Oncology · 2001 · 26 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Should High-Dose Interleukin-2 Still Be the Preferred Treatment for Patients with Metastatic Melanoma?

Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen et al. · Cancer Biotherapy and Radiopharmaceuticals · 2012 · 23 citations

Medicine, Oncology, Pharmacotherapy +13

Treatment of Kidney Cancer with Autologous Tumor Cell Vaccines of Short-Term Cell Lines Derived from Renal Cell Carcinoma

Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen et al. · Cancer Biotherapy and Radiopharmaceuticals · 2001 · 23 citations

Medicine, Immunology, Oncology +17

Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment

Robert O. Dillman, Edward F. McClay, Neil M. Barth et al. · Cancer Biotherapy and Radiopharmaceuticals · 2015 · 22 citations · Full text

Medicine, Immunology, Oncology +17

Autologous Tumor Cell Line–Derived Vaccine for Patient-Specific Treatment of Advanced Renal Cell Carcinoma

Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen et al. · Cancer Biotherapy and Radiopharmaceuticals · 2004 · 20 citations

Medicine, Immunology, Oncology +14